Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

C+D discusses stock shortages on Radio 4's You and Yours

C+D news editor Zoe Smeaton was invited onto Radio 4's You and Yours to discuss stock shortages this week

C+D news editor Zoe Smeaton was invited onto Radio 4's You and Yours to discuss stock shortages this week.


Ms Smeaton was asked to comment on the shortages situation after a listener called with concerns about delays receiving her medicines.


Pharmacists were having to spend more than an hour every week chasing medicines and were experiencing supply problems with more than 30 medicines, Ms Smeaton told the programme.


She highlighted the recent Devon LPC audit, which showed patients were having to wait on average 4.4 days for medicines, where supply isues occurred.


And asked what could be done to solve the problem, Ms Smeaton highlighted efforts in other European countries, where legal obligations have been on the supply chain to ensure pharmacies and patients are supplied with medicines promptly.


To listen to the clip from You and Yours, click here.

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD013851

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel